openPR Logo
Press release

Benign Prostatic Hyperplasia (BPH) Treatment Devices Market 2020-2030 Growth Analysis by Key Players Karl Storz, Lumenis, Olympus, Urologix, Boston scientific Inc.

Benign Prostatic Hyperplasia Treatment Devices And Equipment Market

Benign Prostatic Hyperplasia Treatment Devices And Equipment Market

The Business Research Company offers “Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2020-30: Covid 19 Impact And Recovery" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The global benign prostatic hyperplasia (bph) treatment devices and equipment market is expected to decline from $4.5 billion in 2019 to $4.1 billion in 2020 at a compound annual growth rate (CAGR) of -8.8%. The decline is mainly because of worldwide supply and demand mismatches of resources due to the COVID-19 outbreak. There is an inadequate production of nephrology and urology devices due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing to contain the spread of virus and keep the staff safe. The market is then expected to recover and grow at a CAGR of 4.3% from 2021 and reach $5.3 billion in 2023.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431

The benign prostatic hyperplasia (BPH) treatment devices and equipment market consists of sales of benign prostatic hyperplasia (BPH) treatment devices and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of an enlarged prostate gland which causes blockade of urethra, the tube that carries urine from the bladder. The market is segmented into resectoscopes, radiofrequency ablation device, urology lasers, prostatic stents and implants.

Prostatic Astery Embolization (PAE) is one of the latest developments in the market for Benign Prostatic Hyperplasia (BPH) treatment device and equipment. PAE is a minimally invasive treatment that assists in reducing the symptoms observed in urinary tract. The PAE procedure is done using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery.

Benign Prostatic Hyperplasia Treatment Devices And Equipment Market Segmentation:
By product type:
1.Resectoscopes
2.Radiofrequency ablation device
3.Urology lasers
4. Prostatic Stents
5. Implants

By End-User:
1.Hospitals,
2. Ambulatory Surgical Centres (ASC)
3. Clinics, Home

By Procedure Type:
1.Transurethral Needle Ablation (TUNA)
2.Transurethral Resection of Prostate (TURP)

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Characteristics
3. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Size And Growth
4. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Segmentation
5. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Regional And Country Analysis
……
26. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia Treatment Devices and Equipment Market
27. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Trends And Strategies
28. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the Benign Prostatic Hyperplasia Treatment Devices And Equipment Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

Some of the key players involved in the Benign Prostatic Hyperplasia Treatment Devices And Equipment Market are Karl Storz, Lumenis, Olympus, Urologix, Boston scientific Inc.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benign Prostatic Hyperplasia (BPH) Treatment Devices Market 2020-2030 Growth Analysis by Key Players Karl Storz, Lumenis, Olympus, Urologix, Boston scientific Inc. here

News-ID: 2134960 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Prostatic

Rising Geriatric Population Drives Growth Of Benign Prostatic Hypertrophy Drugs …
The Drugs For Benign Prostatic hypertrophy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Drugs For Benign Prostatic hypertrophy Market? The drugs for benign prostatic hypertrophy market has shown strong growth, expanding from $4.28 billion in 2024 to $4.58
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.